William B. Brinkman, MD, MEd, MSc

A photo of William Brinkman.

Director, Division of General and Community Pediatrics, Carl Weihl Professor of Pediatrics

Member, Center for ADHD

Member, Center for Innovation in Chronic Disease Care

Professor, UC Department of Pediatrics

513-636-2576

Board Certified

My Biography & Research

Biography

My path to becoming a pediatrician started when I had medical problems at age 10. Seeing the impact doctors had on my entire family inspired me to pursue a career in medicine.

I practice primary care pediatrics, and I enjoy getting to know what is most important to patients and families when choosing treatment options. My own experiences as a patient showed me the importance of effective communication, especially when multiple medically reasonable options may differ in meaningful ways.

In addition to practicing medicine and conducting research, I serve as the Carl Weihl Professor of Pediatrics and director of the Division of General & Community Pediatrics at Cincinnati Children’s. In these roles, I have the privilege of leading a diverse, talented, multidisciplinary team who share a passion and commitment to transform primary care delivery and improve population health. We seek to do this through exceptional clinical programs, high-impact clinical and translational research, innovative educational programs, and effective academic and community partnerships.

In my research, I’m looking for ways to make it easier for children and parents to achieve their goals in partnership with their healthcare providers.

When I’m not at work, I enjoy spending time with my wife and two children.

Clinical Interests

Shared decision making; knowledge translation; family centered care; quality improvement; implementation science; attention-deficit/hyperactivity disorder (ADHD); asthma; family/self-management of chronic conditions

Academic Affiliation

Professor, UC Department of Pediatrics

Divisions

Hospital Medicine, Primary Care, Attention Deficit Hyperactivity Disorder ADHD, General and Community Pediatrics, Attention Deficit Hyperactivity Disorder ADHD, Hospital Medicine, General and Community Pediatrics

My Education

MD: St. Louis University, St. Louis, MO, 1999.

Residency: Pediatrics, The Children's Memorial Hospital, Northwestern University, Feinberg School of Medicine, Chicago, IL, 2002.

Chief Residency: Pediatrics, The Children's Memorial Hospital, Chicago, IL, 2003.

Fellowship: NRSA Primary Care Research Fellowship, General & Community Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2006.

MEd: University of Cincinnati, Cincinnati, OH, 2006.

MSc: University of Cincinnati, Cincinnati, OH, 2013.

Certification: Pediatrics, 2002.

My Publications

Pre-Existing Comorbid Emotional Symptoms Moderate Short-Term Methylphenidate Adverse Effects in a Randomized Trial of Children with Attention-Deficit/Hyperactivity Disorder. Froehlich, TE; Brinkman, WB; Peugh, JL; Piedra, AN; Vitucci, DJ; Epstein, JN. Journal of Child and Adolescent Psychopharmacology. 2020; 30:137-147.

Factors Associated with Attention Deficit Hyperactivity Disorder Medication Use in Community Care Settings. Kamimura-Nishimura, KI; Epstein, JN; Froehlich, TE; Peugh, J; Brinkman, WB; Baum, R; Gardner, W; Langberg, JM; Lichtenstein, P; Chen, D; et al. The Journal of Pediatrics. 2019; 213:155-162.e1.

Strategies for improving ADHD medication adherence. Kamimura-Nishimura, KI; Brinkman, WB; Froehlich, TE. Current psychiatry. 2019; 18:11-20.

Development of a Hydroxyurea Decision Aid for Parents of Children With Sickle Cell Anemia. Crosby, LE; Walton, A; Shook, LM; Ware, RE; Treadwell, M; Saving, KL; Britto, M; Peugh, J; McTate, E; Oyeku, S; et al. Journal of Pediatric Hematology/Oncology. 2019; 41:56-63.

Attention-Deficit/Hyperactivity Disorder-Related Deficits and Psychostimulant Medication Effects on Comprehension of Audiovisually Presented Educational Material in Children. Orban, SA; Karamchandani, TA; Tamm, L; Sidol, CA; Peugh, J; Froehlich, TE; Brinkman, WB; Estell, N; Mii, AE; Epstein, JN. Journal of Child and Adolescent Psychopharmacology. 2018; 28:727-738.

Adolescent and Parental Attitudes About Return of Genomic Research Results: Focus Group Findings Regarding Decisional Preferences. McGowan, ML; Prows, CA; DeJonckheere, M; Brinkman, WB; Vaughn, L; Myers, MF. Journal of Empirical Research on Human Research Ethics. 2018; 13:371-382.

Guideline Adoption for Community-Acquired Pneumonia in the Outpatient Setting. Ambroggio, L; Mangeot, C; Murtagh Kurowski, E; Graham, C; Korn, P; Strasser, M; Cavallo, C; Brady, K; Campanella, S; Clohessy, C; et al. Pediatrics. 2018; 142:e20180331-e20180331.

Predictors of Medication Continuity in Children With ADHD. Brinkman, WB; Sucharew, H; Majcher, JH; Epstein, JN. Pediatrics. 2018; 141:e20172580-e20172580.

Characteristics of Treatment Decisions to Address Challenging Behaviors in Children with Autism Spectrum Disorder. Anixt, JS; Meinzen-Derr, J; Estridge, H; Smith, L; Brinkman, WB. Journal of Developmental and Behavioral Pediatrics. 2018; 39:282-291.

Sluggish Cognitive Tempo as a Possible Predictor of Methylphenidate Response in Children With ADHD: A Randomized Controlled Trial. Froehlich, TE; Becker, SP; Nick, TG; Brinkman, WB; Stein, MA; Peugh, J; Epstein, JN. Journal of Clinical Psychiatry. 2018; 79:17m11553-17m11553.